Logo image of HUN

HUNTSMAN CORP (HUN) Stock Fundamental Analysis

NYSE:HUN - New York Stock Exchange, Inc. - US4470111075 - Common Stock - Currency: USD

11.06  +0.64 (+6.14%)

After market: 11 -0.06 (-0.54%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HUN. HUN was compared to 85 industry peers in the Chemicals industry. HUN has a bad profitability rating. Also its financial health evaluation is rather negative. HUN has a expensive valuation and it also scores bad on growth. HUN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HUN has reported negative net income.
In the past year HUN had a positive cash flow from operations.
HUN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years HUN had a positive operating cash flow.
HUN Yearly Net Income VS EBIT VS OCF VS FCFHUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

HUN's Return On Assets of -2.17% is on the low side compared to the rest of the industry. HUN is outperformed by 67.06% of its industry peers.
Looking at the Return On Equity, with a value of -5.37%, HUN is doing worse than 65.88% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.19%, HUN is doing worse than 74.12% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HUN is below the industry average of 6.84%.
Industry RankSector Rank
ROA -2.17%
ROE -5.37%
ROIC 1.19%
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
HUN Yearly ROA, ROE, ROICHUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

Looking at the Operating Margin, with a value of 1.44%, HUN is doing worse than 76.47% of the companies in the same industry.
HUN's Operating Margin has declined in the last couple of years.
The Gross Margin of HUN (14.49%) is worse than 72.94% of its industry peers.
HUN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.44%
PM (TTM) N/A
GM 14.49%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
HUN Yearly Profit, Operating, Gross MarginsHUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

2

2. Health

2.1 Basic Checks

HUN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HUN has more shares outstanding
Compared to 5 years ago, HUN has less shares outstanding
HUN has a worse debt/assets ratio than last year.
HUN Yearly Shares OutstandingHUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HUN Yearly Total Debt VS Total AssetsHUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.67, we must say that HUN is in the distress zone and has some risk of bankruptcy.
HUN's Altman-Z score of 1.67 is on the low side compared to the rest of the industry. HUN is outperformed by 60.00% of its industry peers.
The Debt to FCF ratio of HUN is 25.71, which is on the high side as it means it would take HUN, 25.71 years of fcf income to pay off all of its debts.
HUN has a Debt to FCF ratio of 25.71. This is comparable to the rest of the industry: HUN outperforms 44.71% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that HUN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.57, HUN is in line with its industry, outperforming 58.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 25.71
Altman-Z 1.67
ROIC/WACC0.15
WACC8.03%
HUN Yearly LT Debt VS Equity VS FCFHUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.48 indicates that HUN should not have too much problems paying its short term obligations.
HUN has a worse Current ratio (1.48) than 68.24% of its industry peers.
HUN has a Quick Ratio of 1.48. This is a bad value and indicates that HUN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HUN (0.82) is worse than 77.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 0.82
HUN Yearly Current Assets VS Current LiabilitesHUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

3

3. Growth

3.1 Past

HUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -220.00%.
Looking at the last year, HUN shows a small growth in Revenue. The Revenue has grown by 0.02% in the last year.
HUN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.35% yearly.
EPS 1Y (TTM)-220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.33%
Revenue 1Y (TTM)0.02%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%-4.08%

3.2 Future

Based on estimates for the next years, HUN will show a very strong growth in Earnings Per Share. The EPS will grow by 143.43% on average per year.
The Revenue is expected to grow by 2.54% on average over the next years.
EPS Next Y-450.45%
EPS Next 2Y138.41%
EPS Next 3Y143.43%
EPS Next 5YN/A
Revenue Next Year-1.4%
Revenue Next 2Y1.8%
Revenue Next 3Y2.54%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HUN Yearly Revenue VS EstimatesHUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
HUN Yearly EPS VS EstimatesHUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

HUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 42.89, HUN can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, HUN is valued a bit more expensive than 69.41% of the companies in the same industry.
HUN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.70.
Industry RankSector Rank
PE N/A
Fwd PE 42.89
HUN Price Earnings VS Forward Price EarningsHUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HUN is valued a bit cheaper than 63.53% of the companies in the same industry.
65.88% of the companies in the same industry are more expensive than HUN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.29
EV/EBITDA 9.15
HUN Per share dataHUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as HUN's earnings are expected to grow with 143.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y138.41%
EPS Next 3Y143.43%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.57%, HUN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.69, HUN pays a better dividend. On top of this HUN pays more dividend than 94.12% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, HUN pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.57%

5.2 History

On average, the dividend of HUN grows each year by 9.05%, which is quite nice.
HUN has paid a dividend for at least 10 years, which is a reliable track record.
HUN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)9.05%
Div Incr Years4
Div Non Decr Years17
HUN Yearly Dividends per shareHUN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of HUN are negative and hence is the payout ratio. HUN will probably not be able to sustain this dividend level.
The dividend of HUN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-110.83%
EPS Next 2Y138.41%
EPS Next 3Y143.43%
HUN Yearly Income VS Free CF VS DividendHUN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

HUNTSMAN CORP

NYSE:HUN (7/1/2025, 8:32:44 PM)

After market: 11 -0.06 (-0.54%)

11.06

+0.64 (+6.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners89.13%
Inst Owner Change2.15%
Ins Owners5.31%
Ins Owner Change4.6%
Market Cap1.92B
Analysts64.76
Price Target14.36 (29.84%)
Short Float %5.1%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield 9.57%
Yearly Dividend1.01
Dividend Growth(5Y)9.05%
DP-110.83%
Div Incr Years4
Div Non Decr Years17
Ex-Date06-13 2025-06-13 (0.25)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-76.47%
Min EPS beat(2)-152.09%
Max EPS beat(2)-0.84%
EPS beat(4)1
Avg EPS beat(4)-37.63%
Min EPS beat(4)-152.09%
Max EPS beat(4)4.35%
EPS beat(8)1
Avg EPS beat(8)-27.85%
EPS beat(12)3
Avg EPS beat(12)-20.94%
EPS beat(16)7
Avg EPS beat(16)-13.35%
Revenue beat(2)0
Avg Revenue beat(2)-3.33%
Min Revenue beat(2)-6.25%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-2.91%
Min Revenue beat(4)-6.25%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-2.39%
Revenue beat(12)2
Avg Revenue beat(12)-2.31%
Revenue beat(16)3
Avg Revenue beat(16)-3.03%
PT rev (1m)-2.66%
PT rev (3m)-30.94%
EPS NQ rev (1m)-94.27%
EPS NQ rev (3m)-227.06%
EPS NY rev (1m)-62.02%
EPS NY rev (3m)-447.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.65%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-5.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 42.89
P/S 0.32
P/FCF 25.29
P/OCF 7.57
P/B 0.66
P/tB 0.98
EV/EBITDA 9.15
EPS(TTM)-0.12
EYN/A
EPS(NY)0.26
Fwd EY2.33%
FCF(TTM)0.44
FCFY3.95%
OCF(TTM)1.46
OCFY13.22%
SpS34.39
BVpS16.83
TBVpS11.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.17%
ROE -5.37%
ROCE 1.51%
ROIC 1.19%
ROICexc 1.27%
ROICexgc 1.55%
OM 1.44%
PM (TTM) N/A
GM 14.49%
FCFM 1.27%
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
ROICexc(3y)4.26%
ROICexc(5y)5.51%
ROICexgc(3y)5.21%
ROICexgc(5y)6.86%
ROCE(3y)4.87%
ROCE(5y)5.65%
ROICexcg growth 3Y-54.19%
ROICexcg growth 5Y-26.52%
ROICexc growth 3Y-53.71%
ROICexc growth 5Y-28.3%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 25.71
Debt/EBITDA 4.45
Cap/Depr 61.59%
Cap/Sales 2.98%
Interest Coverage 1.18
Cash Conversion 67.73%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 0.82
Altman-Z 1.67
F-Score5
WACC8.03%
ROIC/WACC0.15
Cap/Depr(3y)81.07%
Cap/Depr(5y)89.35%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.33%
EPS Next Y-450.45%
EPS Next 2Y138.41%
EPS Next 3Y143.43%
EPS Next 5YN/A
Revenue 1Y (TTM)0.02%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%-4.08%
Revenue Next Year-1.4%
Revenue Next 2Y1.8%
Revenue Next 3Y2.54%
Revenue Next 5YN/A
EBIT growth 1Y115%
EBIT growth 3Y-53.86%
EBIT growth 5Y-29.79%
EBIT Next Year154.68%
EBIT Next 3Y67.52%
EBIT Next 5YN/A
FCF growth 1Y-82.16%
FCF growth 3Y-49.41%
FCF growth 5Y-33.84%
OCF growth 1Y-62.37%
OCF growth 3Y-34.87%
OCF growth 5Y-21.76%